COMP <GO>
MSM vs TMO // OPERATING MARGIN
MSC Industrial Direct Company Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MSM 6
— TMO 9
▲ OPERATING MARGIN LEADER: TMO
LAST: $121.02 (-1.55%) • MKT CAP: $6.87B
operating-margins
8.00%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
operating-margins
17.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MSM VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MSM | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 40.80% | 41.00% | -0.20 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.20% | 9.30% | +3.90 | MSM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.2x | 30.4x | -11.20 | MSM | /valuation <GO> |
| Free Cash Flow Yield | 3.51% | 2.40% | +1.11 | MSM | /fcf-yield <GO> |
| Operating Margin ACTIVE | 8.00% | 17.40% | -9.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | 5.30% | 15.10% | -9.80 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -1.30% | 3.90% | -5.20 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.14 | 4.50 | +1.64 | MSM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.70% | +0.40 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.5 | 59.1 | -13.63 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 0.94 | +0.11 | MSM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.0x | 36.3x | -4.30 | MSM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.87B | $262.22B | -$255.35B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MSM REV | TMO REV | MSM GROSS % | TMO GROSS % | MSM FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.77B | $44.56B | 40.8% | 44.0% | $240.9M | $6.29B |
| FY 2024 | $3.82B | $42.88B | 41.2% | 44.0% | $311.3M | $7.27B |
| FY 2023 | $4.01B | $42.86B | 44.0% | 44.0% | $519.2M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MSM // BETA 1.05
TMO // BETA 0.94